Eli Lilly is making it cheaper for some hospitals to buy its blood-thinning drug ReoPro, as a marketing battle with Integrilin, a competing drug sold by Millennium Pharmaceuticals , continues to heat ...
Johnson & Johnson and Eli Lilly have permanently halted a clinical trial of their antithrombotic drug ReoPro (abciximab) in patients with acute ischaemic stroke. Johnson & Johnson and Eli Lilly have ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Abciximab (Reopro) blocks the sticking of ...
One of the great success stories of biotechnology began at SUNY Stony Brook in the early 1980s. Physician Barry S. Coller, a faculty member and hematology researcher, developed an anti-clotting drug ...
Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "ReoPro (Abciximab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results